Equities

Sisram Medical Ltd

Sisram Medical Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)3.02
  • Today's Change0.02 / 0.67%
  • Shares traded208.80k
  • 1 Year change-64.84%
  • Beta1.7152
Data delayed at least 15 minutes, as of Jul 26 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sisram Medical Ltd is an investment holding company principally engaged in the design, development, manufacture and distribution of energy cosmetic medicine and minimally invasive medical cosmetic treatment systems. The Company has a comprehensive medical cosmetic equipment portfolio, including medical beauty product line and life beauty product line, can be used for noninvasive medical cosmetic treatment, such as hair removal, rejuvenation, skin care, vascular treatment and pigmented lesions treatment, removal of tattoos, acne Treatment, fat reduction, body shaping and firming. The Company's medical cosmetic equipment can also be used for minimally invasive medical cosmetic treatment, such as private beauty treatment, laser liposuction, treatment of varicose veins and treatment of hyperhidrosis. The company sells its products in domestic and foreign markets.

  • Revenue in HKD (TTM)2.80bn
  • Net income in HKD245.89m
  • Incorporated2013
  • Employees1.08k
  • Location
    Sisram Medical LtdOFEK 15 Building18 HaHarash Street, Industrial ParkCAESAREA 3079895IsraelISR
  • Phone+972 46275357
  • Websitehttps://sisram-medical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Guanze Medical Infrm Indstry (Hldng) Ltd168.49m29.76m760.00m56.0025.542.6120.754.510.03130.03130.17740.30620.48765.371.203,008,773.008.72--10.54--54.72--17.89--6.252,148.220.0748---11.88--53.63------
ClouDr Group Ltd3.98bn-348.77m968.61m1.52k--0.4488--0.2431-0.6447-0.64477.373.681.285.484.742,617,744.00-11.33---17.13--24.64---8.87--1.58-29.150.1314--23.51--80.87------
Ziyuanyuan Holdings Group Ltd537.58m15.72m1.22bn184.0072.003.3640.032.260.03930.03931.340.84330.81844.543.022,921,627.002.282.613.673.7124.69--2.786.131.752.340.31354.9653.4152.48-7.90-2.9897.56--
Beijing Airdoc Technology Co Ltd220.19m-143.08m1.31bn339.00--0.7885--5.95-1.38-1.382.1316.060.11912.262.84649,540.60-8.51---9.03--61.35---71.41--11.26--0.006--79.46--26.37------
Sisram Medical Ltd2.80bn245.89m1.41bn1.08k5.750.40063.840.50430.52480.52485.997.540.61471.804.392,597,016.005.635.946.706.8861.1057.669.1610.582.0013.960.086928.791.3618.48-21.597.6146.589.64
IVD Medical Holding Ltd3.33bn257.11m1.45bn803.004.680.33394.880.43390.19020.19022.472.670.67882.785.624,152,108.005.215.186.866.6721.7520.757.687.531.567.530.0923--12.3549.4913.4118.1519.77--
MicroTech Medical Hangzhou Co Ltd273.38m-134.96m1.50bn760.00--0.685--5.50-0.3171-0.31710.64225.230.11372.354.13359,707.80-5.62---5.85--49.13---49.37--21.22--0.00008--45.92---256.75------
Jenscare Scientific Co Ltd0.00-401.32m1.55bn376.00--1.17-----0.962-0.9620.003.190.00----0.00-27.49---28.61----------19.20--0.0347------15.38------
Gaush Meditech Ltd1.52bn187.33m1.66bn869.008.850.91356.171.091.271.2710.2612.260.50572.348.851,746,994.006.22--8.35--49.18--12.30--1.195.900.2814--12.16--149.63------
Peijia Medical Ltd476.23m-423.76m1.75bn1.04k--0.7139--3.68-0.624-0.6240.70113.610.14730.777337.52457,911.70-13.11-34.08-14.94-36.9073.7671.62-88.99-448.756.92--0.0886--75.86--3.75--106.68--
PW Medtech Group Ltd728.80m165.37m1.83bn1.24k11.080.41955.582.510.10560.10560.46552.790.13312.199.21585,854.604.047.234.918.0956.4258.1330.3785.3812.70--0.00024.1125.7516.7844.465.94-7.92--
MicroPort CardioFlow Medtech Corp362.97m-509.06m1.83bn592.00--0.7274--5.05-0.2154-0.21540.15361.040.12052.783.67613,123.30-16.91-17.37-18.11-22.962.06-1.67-140.25-180.829.91-11.560.0293--33.94---3.77---14.16--
Acotec Scientific Holdings Ltd511.55m15.64m1.96bn638.00120.541.4029.963.840.0520.0521.704.470.31360.72133.44801,808.800.9589--1.03--79.65--3.06--9.122.750.1529--19.80---79.35------
Data as of Jul 26 2024. Currency figures normalised to Sisram Medical Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.97%Per cent of shares held by top holders
HolderShares% Held
Segall Bryant & Hamill LLCas of 30 Jun 20241.83m0.39%
China Universal Asset Management Co., Ltd.as of 31 Dec 20231.51m0.32%
Mellon Investments Corp.as of 03 Jul 2024534.00k0.11%
SSgA Funds Management, Inc.as of 03 Jul 2024397.60k0.09%
Atlantis Investment Management Ltd. /Hong Kong/as of 31 Dec 2023206.80k0.04%
Guardians of New Zealand Superannuationas of 30 Jun 202357.60k0.01%
State of Wisconsin Investment Boardas of 31 Dec 202215.20k0.00%
Connor, Clark & Lunn Investment Management Ltd.as of 31 Dec 20231.60k0.00%
LGT Capital Partners AG (Investment Management)as of 30 Nov 20230.000.00%
China Asset Management Co., Ltd.as of 31 Dec 20230.000.00%
More ▼
Data from 30 Jun 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.